International Multispeciality Journal of Health - Singapore Singapore Medical Journal | Biomedical Research Hub | Clinical Research Excellence
Top Medical Journal in Singapore | Premier Biomedical Research Publication
ISSN: 2395-6291 | R Impact Factor: 3.83 | DOI: 10.25125/medical-journal | Indexed in CrossRef, Google Scholar, PubMed Central (in progress), WorldCat
Medical Research Landscape in Singapore: Key Statistics
Biomedical Research Publications
Annually
Research Institutes &
Centers of Excellence
R&D Investment
(2020-2025)
In Asia for Biomedical
Research Quality
Source: Agency for Science, Technology and Research (A*STAR), National Medical Research Council (NMRC), Ministry of Health Singapore, 2024 Research Report
Medical Research Landscape in Singapore | Singapore's Biomedical Sciences Hub
Singapore, a global city-state with a population of over 5.5 million, has established itself as Asia's premier biomedical sciences hub and a world leader in medical research. The nation's strategic investment in research infrastructure, coupled with its world-class healthcare system and strong intellectual property protection, has created an exceptional environment for cutting-edge medical and pharmaceutical innovation. Through initiatives like the Research, Innovation and Enterprise (RIE) 2025 plan, the National Medical Research Council (NMRC), and Biopolis - Singapore's biomedical research hub, the country continues to push the boundaries of translational medicine, precision oncology, and infectious disease research.
Biomedical & Translational Research | Penyelidikan Bioperubatan & Translasi
Singapore is a global leader in biomedical sciences, with world-class expertise in precision medicine, genomics, immunology, and stem cell research. The country's integrated research ecosystem connects basic science with clinical applications.
Clinical Research Excellence | Kecemerlangan Penyelidikan Klinikal
Singapore's world-class healthcare system, including SingHealth, National University Health System (NUHS), and National Healthcare Group (NHG), provides an exceptional platform for clinical research and translational medicine.
About IMJ Health: Your Partner in Medical Research
The International Multispeciality Journal of Health (IMJ Health) is a prestigious, peer-reviewed, open-access journal dedicated to advancing medical and pharmaceutical sciences globally. We provide Singaporean researchers, clinicians, and healthcare professionals with a respected platform to publish their groundbreaking findings and contribute to the global medical community.
With our commitment to quality, speed, and visibility, IMJ Health ensures that research from Singapore reaches a worldwide audience, fostering collaboration and knowledge exchange that addresses both local and global health challenges. Our journal complements Singapore's vision of becoming a global biomedical research hub.
Open Access
Global VisibilityRapid Review
4-6 weeksGlobal Indexing
PubMed Central (in progress)Top Singapore Institutions Publishing in IMJ Health
Researchers from these leading Singaporean institutions have published their work in IMJ Health, contributing to the advancement of medical science:
- National University of Singapore (NUS)
- Nanyang Technological University (NTU)
- Duke-NUS Medical School
- Singapore General Hospital (SGH)
- National University Hospital (NUH)
- Tan Tock Seng Hospital (TTSH)
- Agency for Science, Technology and Research (A*STAR)
- Singapore Institute for Clinical Sciences (SICS)
- Lee Kong Chian School of Medicine
Singapore's Medical Research Priorities (RIE 2025)
The National Medical Research Council (NMRC) and Agency for Science, Technology and Research (A*STAR) have identified key priority areas under the Research, Innovation and Enterprise (RIE) 2025 plan:
Precision Medicine & Genomics
- Singapore Precision Medicine Initiative (SG100K)
- Cancer genomics and targeted therapies
- Pharmacogenomics and personalized treatment
- Rare disease research and diagnostics
- Epigenetics and disease mechanisms
Infectious Disease & Antimicrobial Resistance
- Emerging infectious diseases (COVID-19, dengue)
- Antimicrobial resistance surveillance
- Vaccine development and immunology
- Global health security
- Host-pathogen interactions
Neuroscience & Mental Health
- Dementia and aging research
- Mental health in Asian populations
- Neurodegenerative diseases
- Brain-computer interfaces
- Cognitive neuroscience
Digital Health & MedTech
- Artificial Intelligence in healthcare
- Health informatics and big data
- Telemedicine and remote monitoring
- Wearable devices and diagnostics
- Medical robotics and imaging
Cardiovascular & Metabolic Diseases
- Diabetes and obesity research
- Cardiovascular disease prevention
- Metabolic syndrome in Asian populations
- Regenerative medicine
- Vascular biology
Pharmaceutical Innovation & Drug Discovery
- Small molecule drug discovery
- Biologics and cell therapy
- mRNA vaccine development
- Natural product research
- Formulation science
Singapore's World-Class Research Institutions
Singapore's biomedical research ecosystem is anchored by Biopolis and the Agency for Science, Technology and Research (A*STAR). These world-class facilities bring together public sector research institutes, corporate laboratories, and academic institutions in a collaborative environment that accelerates translational research from bench to bedside.
Biopolis
A*STAR Research Institutes
- Genome Institute of Singapore (GIS)
- Singapore Immunology Network (SIgN)
- Institute of Molecular and Cell Biology (IMCB)
- Bioinformatics Institute (BII)
- Institute of Bioengineering and Nanotechnology (IBN)
Academic Medical Centers
- SingHealth Duke-NUS Academic Medical Centre
- National University Health System (NUHS)
- National Healthcare Group (NHG)
- Lee Kong Chian School of Medicine
- Duke-NUS Medical School
Clinical Research Networks
- Singapore Clinical Research Institute (SCRI)
- National Medical Research Council (NMRC)
- Experimental Therapeutics Centre (ETC)
- Advanced Cell Therapy and Research Institute (ACTRIS)
Infectious Disease Research
- Emerging Infectious Diseases Programme (EID)
- National Centre for Infectious Diseases (NCID)
- Duke-NUS Centre for Outbreak Preparedness
- Saw Swee Hock School of Public Health
Why Singaporean Researchers Choose IMJ Health
Rigorous Peer Review
Double-blind peer review ensures quality, reliability, and credibility of published research, enhancing your academic reputation.
High Visibility & Impact
Indexed in Google Scholar, CrossRef, WorldCat, and Index Copernicus. We are actively pursuing PubMed Central indexing to maximize global visibility.
Rapid Publication
Efficient editorial workflow with average publication time of 4-6 weeks from submission to online publication.
CrossRef DOI Registration
Every published article receives a unique DOI, ensuring permanent accessibility and citation tracking.
Frequently Asked Questions
Comprehensive FAQ for Singaporean Authors
Find answers about submission process, peer review, publication fees, indexing status, and more for Singaporean medical researchers.
The average time from submission to publication is 4-6 weeks for articles from Singaporean researchers. Our streamlined peer review process ensures rapid publication without compromising quality.
Yes, IMJ Health is currently indexed in Google Scholar, CrossRef, WorldCat, and Index Copernicus. We are actively pursuing indexing in PubMed Central (PMC) to meet the high standards expected by Singaporean researchers and institutions. Our commitment to quality and ethical publishing aligns with PMC requirements.
Current Indexing Status:
- Google Scholar
- CrossRef (DOI Member)
- WorldCat
- Index Copernicus
- PubMed Central (PMC) - Application in Process
Yes, absolutely! IMJ Health welcomes research funded by the National Medical Research Council (NMRC), Agency for Science, Technology and Research (A*STAR), Ministry of Health Singapore, and other funding agencies. We support Singapore's research ecosystem by providing a high-visibility platform for funded research outputs.
- Precision medicine and genomics research
- Clinical trials and translational medicine
- Infectious disease and vaccine development
- Digital health and AI in healthcare
- Biomedical engineering and MedTech
Publication fees vary based on article type and length. We offer competitive rates for researchers from Singaporean institutions. Many funding agencies, including NMRC and A*STAR, allow publication fees as part of research grants.
Academic Faculty
$100 (USD)
Approx. SGD 135
Students/Scholars
$80 (USD)
Approx. SGD 108
You can submit your article online via the Submit Article Link on the journal's homepage. You can also email your submission to info@imjhealth.org or info.imjh@gmail.com. Electronic submission helps reduce processing time and speeds up publication.
Yes, IMJ Health strictly adheres to international ethical standards and complies with the Singapore Statement on Research Integrity. Our editorial policies align with the Committee on Publication Ethics (COPE) guidelines and meet the requirements of Singaporean institutions for research publication.
You can contact our editorial office through multiple channels:
WhatsApp:
+65 12 345 6789 (for Singaporean authors)
Response within 24 hours on business days
Join Singapore's World-Class Research Community
Share your research with the global medical community. IMJ Health is your trusted partner in advancing medical science from Singapore to the world.
Submit Your Research
Online Submission
https://imjhealth.org/submit-article
Fast, secure, and user-friendly submission portal